The Use of Ghrelin and Ghrelin Receptor Agonists as a Treatment for Animal Models of Disease: Efficacy and Mechanism

E-ISSN： 1873-4286|18|31|4779-4799

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.31, 2012-10, pp. : 4779-4799

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ghrelin and ghrelin receptor inhibitors: agents in the treatment of obesity

By Soares João-Bruno Roncon-Albuquerque Roberto Leite-Moreira Adelino

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 9, 2008-09 ,pp. : 1177-1189

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in ghrelin receptor (GHS-R1a) agonists and antagonists

By Carpino Philip A

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1599-1618

Informa Healthcare

Access to resources Recommend Favorite

Muscarinic Receptor Agonists and Antagonists in the Treatment of Alzheimer's Disease

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3353-3361

Bentham Science Publishers

Access to resources Recommend Favorite

5HT2C receptor agonists and antagonists in animal models of anxiety

By Martin J.R. Bouml s M. Jenck F. Kouml hler C. Moreau J.-L. Sleight A.J. Stadler H. Wichmann J.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 209-209

Elsevier

Access to resources Recommend Favorite

Antidepressant-like Effects of δ Opioid Receptor Agonists in Animal Models

Current Neuropharmacology, Vol. 10, Iss. 3, 2012-09 ,pp. : 231-238

Bentham Science Publishers

Access to resources Recommend Favorite